Top Media Providers

Analysts downgrade Marvell and slash price targets over Lumentum deal By Investing.com

Investing.com AustraliaBy Investing.com Australia

11/3/2026, 1:14:24 PM

EXECUTIVE SUMMARY

Analysts downgrade Marvell and slash price targets over Lumentum deal By Investing.com Investing.com Australia

Analysts downgrade Marvell and slash price targets over Lumentum deal By Investing.com.

Analysts downgrade Marvell and slash price targets over Lumentum deal By Investing.com  Investing.com Australia

Published originally on Investing.com Australia

Finance & Markets14m ago

Why is Travere Therapeutics stock sliding today?....

Investing.com

Finance & Markets14m ago

Why is Vertex Pharmaceuticals stock rallying today?....

Investing.com

Finance & Markets14m ago

Why is Match stock ticking down today?....

Investing.com

Finance & Markets14m ago

Netanyahu urged U.S. to resume Iran strikes after midterms, AP says....

Investing.com

Multikhabar App

Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!